参考文献/References:
[1]Ommen SR,Mital S,Burke MA,et al.2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy:a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol,2020,76(25):e159-e240.
[2]Wang S,Cui H,Tang B,et al.Midterm outcomes of simultaneous coronary artery bypass graft surgery and septal myectomy in patients with hypertrophic obstructive cardiomyopathy:a casecontrolled study.J Card Surg,2019,34(3):103-109.
[3]Zhai SS,Fan CM,An SY,et al.Clinical outcomes of myocardial bridging versus no myocardial bridging in patients with apical hypertrophic cardiomyopathy.Cardiology,2018,139(3):161-168.
[4]Song C,Wang S,Guo Y,et al.Preoperative NTproBNP predicts midterm outcome after septal myectomy.J Am Heart Assoc,2019,8(4):e011075.
[5]Cui H,Schaff HV,Geske JB,et al.Early septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy.J Thorac Cardiovasc Surg,2020 Oct 28:S0022-5223(20)32884-1.Online ahead of print.
[6]Maron B.Clinical course and management of hypertrophic cardiomyopathy.N Engl J Med,2018,379(7):655-668.
[7]蔡红,蔡玲娜,俞裕玉.肥厚型梗阻性心肌病行改良扩大室间隔心肌切除术13例围术期护理.福建医药杂志,2021,43(5):146-147.